A Phase I Study for Safety and Tolerability of AL002.

NCT03635047 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

69

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy
Alzheimer Disease

Interventions

BIOLOGICAL: AL002
OTHER: Saline Solution

Sponsor

Alector Inc.